BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30399441)

  • 1. Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica.
    Oliaee RT; Sharifi I; Afgar A; Jafarzadeh A; Kareshk AT; Bamorovat M; Sharifi H; Babaei Z; Keyhani A; Keyhani A; Abedi L; Sharifi F
    Microb Pathog; 2019 Jan; 126():368-378. PubMed ID: 30399441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling.
    Oliaee RT; Sharifi I; Afgar A; Kareshk AT; Asadi A; Heshmatkhah A; Bamorovat M; Jafarzadeh A; Mohammadi MA; Daneshvar H
    Trop Med Int Health; 2018 Jun; 23(6):622-633. PubMed ID: 29709098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.
    Bamorovat M; Sharifi I; Fekri A; Keyhani A; Aflatoonian MR; Heshmatkhah A; Oliaee RT; Khosravi A; Naderi A; Parizi MH; Mostafavi M; Varma RS
    Microb Pathog; 2019 Mar; 128():162-170. PubMed ID: 30583021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways.
    Bamorovat M; Sharifi I; Aflatoonian MR; Sadeghi B; Shafiian A; Oliaee RT; Keyhani A; Afshar AA; Khosravi A; Mostafavi M; Parizi MH; Khatami M; Arefinia N
    Int Immunopharmacol; 2019 Apr; 69():321-327. PubMed ID: 30771740
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Polari LP; Carneiro PP; Macedo M; Machado PRL; Scott P; Carvalho EM; Bacellar O
    Front Cell Infect Microbiol; 2019; 9():120. PubMed ID: 31119102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime.
    Ezatkhah F; Sharifi I; Babaei Z; Baneshi MR; Zolala F; Kermanizadeh A; Keyhani A; Sharifi M; Dezaki ES; Aflatoonian MR; Aflatoonian B; Khatami M; Bamorovat M
    J Vector Borne Dis; 2019; 56(4):351-359. PubMed ID: 33269736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling.
    Oliaee RT; Sharifi I; Bamorovat M; Keyhani A; Babaei Z; Salarkia E; Tavakoly R; Khosravi A; Mostafavi M; Sharifi F; Mousavi SM
    Int Immunopharmacol; 2020 Sep; 86():106704. PubMed ID: 32590317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
    Hadighi R; Mohebali M; Boucher P; Hajjaran H; Khamesipour A; Ouellette M
    PLoS Med; 2006 May; 3(5):e162. PubMed ID: 16605301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran.
    Nateghi-Rostami M; Tasbihi M; Darzi F
    Acta Trop; 2022 Jun; 230():106392. PubMed ID: 35276060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.
    Gatto M; de Abreu MM; Tasca KI; de Assis Golim M; da Silva LD; Simão JC; Fortaleza CM; de Campos Soares ÂM; Calvi SA
    PLoS One; 2015; 10(2):e0117977. PubMed ID: 25706930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
    Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
    PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran.
    Bamorovat M; Sharifi I; Aflatoonian MR; Sharifi H; Karamoozian A; Sharifi F; Khosravi A; Hassanzadeh S
    PLoS One; 2018; 13(2):e0192236. PubMed ID: 29415078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR2 and TLR4 in cutaneous leishmaniasis caused by Leishmania major.
    Tolouei S; Hejazi SH; Ghaedi K; Khamesipour A; Hasheminia SJ
    Scand J Immunol; 2013 Nov; 78(5):478-84. PubMed ID: 23980810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.
    Aflatoonian MR; Sharifi I; Aflatoonian B; Bamorovat M; Heshmatkhah A; Babaei Z; Ghasemi Nejad Almani P; Mohammadi MA; Salarkia E; Aghaei Afshar A; Sharifi H; Sharifi F; Khosravi A; Khatami M; Arefinia N; Fekri A; Farajzadeh S; Khamesipour A; Mohebali M; Gouya MM; Shirzadi MR; Varma RS
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007423. PubMed ID: 31188834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR9-deficiency reduces TLR1, TLR2 and TLR3 expressions in Leishmania major-infected macrophages.
    Pandey SP; Doyen N; Mishra GC; Saha B; Chandel HS
    Exp Parasitol; 2015 Jul; 154():82-6. PubMed ID: 25911242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica.
    Sezavar M; Sharifi I; Ghasemi Nejad Almani P; Kazemi B; Davoudi N; Salari S; Salarkia E; Khosravi A; Bamorovat M
    J Clin Lab Anal; 2021 Mar; 35(3):e23670. PubMed ID: 33283321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis.
    Roy S; Mukhopadhyay D; Mukherjee S; Ghosh S; Kumar S; Sarkar K; Pal D; Bhowmik P; Mandal K; Modak D; Guha SK; Pramanik N; Goswami RP; Saha B; Chatterjee M
    J Clin Immunol; 2015 Jan; 35(1):56-67. PubMed ID: 25479930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.
    Sánchez-Muñoz F; Fonseca-Camarillo G; Villeda-Ramírez MA; Miranda-Pérez E; Mendivil EJ; Barreto-Zúñiga R; Uribe M; Bojalil R; Domínguez-López A; Yamamoto-Furusho JK
    BMC Gastroenterol; 2011 Dec; 11():138. PubMed ID: 22185629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative proteomics study on meglumine antimoniate sensitive and resistant Leishmania tropica isolated from Iranian anthroponotic cutaneous leishmaniasis patients.
    Hajjaran H; Azarian B; Mohebali M; Hadighi R; Assareh A; Vaziri B
    East Mediterr Health J; 2012 Feb; 18(2):165-71. PubMed ID: 22571094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.